Microvascular Dysfunction in Transgender Men on Testosterone Gender-Affirming Hormone Therapy: Implications for Cardiovascular Risk
Abstract Body: Transgender males (TMs; assigned female at birth) on testosterone gender-affirming hormone therapy (T-GAHT) may experience reduced protective effects of estrogen (E2) typically seen in pre-menopausal cisgender females (CFs). E2 stimulates endothelial receptors, activating endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release, a potent vasodilator. TMs initiating T-GAHT at younger ages may face higher risk of earlier onset cardiovascular disease (CVD). While research on GAHT and CVD has progressed, the effects of T-GAHT on TMs' microvasculature remain understudied. We hypothesized that resistance arterioles from TMs on T-GAHT exhibit endothelial dysfunction compared to CFs.
We collected human resistance arterioles from subcutaneous adipose tissue of healthy TMs, CFs, and cisgender males (CMs) to compare vascular function via endothelium-dependent vasoreactivity by videomicroscopy. Key findings: 1) TMs on T-GAHT (n=8) showed impaired vasodilation to E2 compared to CFs (n=11), similar to levels of CMs(n=4)(p<0.0001 overall). 2) Administration of eNOS inhibitor, L-NAME, decreased vasoreactivity to E2 in CFs and CMs but not in TMs, indicating reduced eNOS-dependent vasodilation in TMs. 3) Acute testosterone exposure in CF arterioles (n=6) mimicked chronic T-GAHT effects of E2 in TMs. 4) Acetylcholine responses suggest normal endothelium-dependent vasodilation in TMs, with L-NAME significantly blunting the response (p<0.01 overall), implying impairment in other pathways. 5) NO donor, NONOate, responses were similar between TMs, CFs, and CMs, indicating normal smooth muscle function (n=3/group). 6) Flow-induced vasodilation was reduced in TMs (n=3) compared to CFs (n=4) and CMs (n=2) at higher pressures (p<0.05) while L-NAME significantly reduced responses in CFs, showed a decreasing trend in CMs, but had no effect in TMs.
These data indicate that resistance arterioles of TMs on T-GAHT exhibit impaired eNOS- and endothelial-dependent vasodilatory capacity, suggesting a potential vasodilator switch. Further research will elucidate specific contributions of NO, H2O2, and prostaglandins. These mechanistic insights are crucial for cardiovascular risk stratification in TMs on T-GAHT.
Roberts, Michelle
( Medical College of Wisconsin
, Milwaukee
, Wisconsin
, United States
)
Westhoff, Justin
( Medical College of Wisconsin
, Milwaukee
, Wisconsin
, United States
)
Wang, Jingli
( Medical College of Wisconsin
, Milwaukee
, Wisconsin
, United States
)
Ying, Rong
( Medical College of Wisconsin
, Milwaukee
, Wisconsin
, United States
)
Cabrera, Susanne
( Medical College of Wisconsin
, Wauwatosa
, Wisconsin
, United States
)
Widlansky, Michael
( Medical College of Wisconsin
, Fox Point
, Wisconsin
, United States
)
Author Disclosures:
Michelle Roberts:DO NOT have relevant financial relationships
| Justin Westhoff:DO NOT have relevant financial relationships
| Jingli Wang:No Answer
| Rong Ying:No Answer
| Susanne Cabrera:No Answer
| Michael Widlansky:No Answer
Wang Jingli, Wilcox Taylor, Hill R., Widlansky Michael, Nolden Kelsey, Egner John, Kakarla Mamatha, Harwig Megan, Roberts Michelle, Arnold Leggy, Hofeld Benjamin, Ying Rong
You have to be authorized to contact abstract author. Please, Login